Lundbeck currently generates the majority of its revenue from Cipralex, sold in the United States as Lexapro.
2
Lundbeck currently generates most of its revenue from antidepressant Cipralex, sold in the United States as Lexapro.
3
Cipralex sales were 990 million crowns, above the average estimate of 982 million crowns.
4
Lundbeck generates most of its revenue from antidepressant Cipralex, sold as Lexapro in the United States by Forest Laboratories.
5
Lundbeck, which currently generates the majority of its revenue from Cipralex, sold in the United States as Lexapro, said it would appeal against the decision.
6
Lundbeck reported Cipralex sales of 1.0 billion crowns in the quarter, up 20 percent, while Lexapro sales rose 47 percent to 641 million crowns.
7
Lundbeck generates the majority of its revenues from Lexapro, sold outside the United States as Cipralex, and the patents for the drug expire in 2012-2014.